撤回：MUC16突变在肝细胞癌患者中的预后价值及其与免疫的相关性
Retracted: Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
作者信息
And Alternative Medicine Evidence-Based Complementary
出版信息
Evid Based Complement Alternat Med. 2023 Jul 19;2023:9754067. doi: 10.1155/2023/9754067. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/3478861.].
摘要
[本文撤回文章DOI: 10.1155/2022/3478861。]
相似文献
1
Retracted: Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.撤回：MUC16突变在肝细胞癌患者中的预后价值及其与免疫的相关性
Evid Based Complement Alternat Med. 2023 Jul 19;2023:9754067. doi: 10.1155/2023/9754067. eCollection 2023.
2
Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.MUC16突变在肝细胞癌患者中的预后价值及其与免疫的相关性
Evid Based Complement Alternat Med. 2022 Aug 18;2022:3478861. doi: 10.1155/2022/3478861. eCollection 2022.
3
Retracted: Prognostic Value of Stem Cell Index-Related Characteristics in Primary Hepatocellular Carcinoma.撤回：干细胞指数相关特征在原发性肝细胞癌中的预后价值。
Contrast Media Mol Imaging. 2023 Jul 19;2023:9850917. doi: 10.1155/2023/9850917. eCollection 2023.
4
Retracted: Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.撤回：肝细胞癌预后免疫相关基因的免疫基因组景观分析。
J Healthc Eng. 2023 Oct 11;2023:9764352. doi: 10.1155/2023/9764352. eCollection 2023.
5
Retracted: Prognostic and Immunological Significance of FUNDC1 in Hepatocellular Carcinoma: A Study on TCGA Mining.撤回：FUNDC1在肝细胞癌中的预后及免疫学意义：基于TCGA数据库挖掘的研究
Comput Math Methods Med. 2023 Nov 29;2023:9818549. doi: 10.1155/2023/9818549. eCollection 2023.
6
Retracted: Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma.撤回：肝细胞癌中与干性基因相关的预后模型的开发与优化
Biomed Res Int. 2024 Jan 9;2024:9815950. doi: 10.1155/2024/9815950. eCollection 2024.
7
Retracted: LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.撤稿：乳酸脱氢酶和γ-谷氨酰转移酶/谷丙转氨酶比值作为肝移植术后肝细胞癌患者的新型预后生物标志物
Comput Math Methods Med. 2023 Dec 6;2023:9764203. doi: 10.1155/2023/9764203. eCollection 2023.
8
Retracted: Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma.撤回：全基因组筛选鉴定肝细胞癌中的预后长链非编码RNA 。
Biomed Res Int. 2023 Nov 29;2023:9841321. doi: 10.1155/2023/9841321. eCollection 2023.
9
Retracted: Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.撤回：在肝内胆管癌和肝细胞癌中具有独特代谢相关基因簇且具有预后意义。
Oxid Med Cell Longev. 2023 Aug 2;2023:9815947. doi: 10.1155/2023/9815947. eCollection 2023.
10
Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.撤回：G蛋白亚基γ5是一种预后生物标志物，与肝细胞癌中的免疫浸润相关。
Dis Markers. 2023 Jul 19;2023:9806936. doi: 10.1155/2023/9806936. eCollection 2023.
本文引用的文献
1
Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.MUC16突变在肝细胞癌患者中的预后价值及其与免疫的相关性
Evid Based Complement Alternat Med. 2022 Aug 18;2022:3478861. doi: 10.1155/2022/3478861. eCollection 2022.
Zotero 插件